Description: Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, Vietnam, Iceland, the Faroe Islands, China, Ecuador, India, Canada, Greece, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was incorporated in 2000 and is headquartered in Sheffield, the United Kingdom.
Home Page: www.benchmarkplc.com
4 Park Square
Sheffield,
S35 2PH
United Kingdom
Phone:
44 11 4240 9939
Officers
| Name | Title |
|---|---|
| Mr. Trond Williksen | CEO & Director |
| Ms. Septima Maguire | CFO & Director |
| Ms. Ruth Layton | Co-Founder & Head of Benchmark Sustainability Science |
| Mr. Neil Robertson | Head of Operations |
| Ms. Ivonne Maria Gloria Cantu | Director of Investor Relations & Corporate Development and Head of Sustainability Working Group |
| Ms. Jennifer Aurelie Mathilde Haddouk | Company Secretary & Group Legal Counsel |
| Ms. Corina Holmes | Group Head of People |
| Mr. Roland James Bonney | Group Lead of Key Account Management |
| Mr. David Babington | Managing Director of Improve International |
| Mr. Jan-Emil Johannessen | Head of Genetics |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 37.7358 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1168 |
| Price-to-Sales TTM: | 2.2569 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 823 |